Latest News

Earlier this month, Cytek Biosciences reported third-quarter 2025 earnings, showing revenue of US$52.29 million and a net loss of US$5.48 million compared to net income in the prior year, and reaffirmed its full-year revenue guidance of US$196 million to US$205 million. This combination of improved quarterly revenue but a swing to quarterly and year-to-date losses provided investors with contrasting signals about Cytek’s ongoing financial health and outlook. We’ll review how the...

Autolus Therapeutics (AUTL) just released its latest quarterly earnings and is drawing increased investor attention thanks to several key developments. The company continues to expand commercial access for Obe-cel, reports strong manufacturing results, and anticipates new data at the upcoming ASH conference. See our latest analysis for Autolus Therapeutics. Autolus Therapeutics has seen a burst of activity lately, from broadening commercial access and updating its leadership team to advancing...

Legence (LGN) shares have moved higher recently, catching investors’ attention after the company reported a strong annual net income improvement and steady revenue growth. The stock is up more than 20% over the past month. See our latest analysis for Legence. Legence’s 1-month share price return of 20.2% is grabbing attention, especially after its annual profit surge. Momentum appears to be building as confidence returns and investors increasingly factor in the company’s growth story. With...

Anavex Life Sciences (AVXL) reported that its lead drug candidate, blarcamesine, for early Alzheimer's disease faced a negative trend vote from the European Medicines Agency's CHMP. This outcome has sparked new questions about regulatory pathways and next steps for the company. See our latest analysis for Anavex Life Sciences. Anavex’s regulatory news contributed to a dramatic shift in sentiment, with the stock’s 1-day share price return tumbling 35.94% and momentum clearly fading. Despite...

EssoF (ENXTPA:ES) just announced a hefty €60.21 per share special dividend, set for November 14, 2025, after shareholders gave the green light during the recent Combined General Meeting. Investors are paying close attention. See our latest analysis for EssoF. That extraordinary dividend comes after an eventful year for EssoF, with the share price recently closing at €47.44. Despite a sharp drop in price over the past month and year-to-date, investors who held on for the past twelve months...

Semperit Aktiengesellschaft Holding ( VIE:SEM ) last week reported its latest quarterly results, which makes it a good...

It's been a pretty great week for ALK-Abelló A/S ( CPH:ALK B ) shareholders, with its shares surging 15% to kr.230 in...

The market rallied behind SpectrumOne AB (publ)'s ( STO:SPEONE ) stock, leading do a rise in the share price after its...

Investors in Infineon Technologies AG ( ETR:IFX ) had a good week, as its shares rose 7.9% to close at €35.30 following...

It's been a pretty great week for De'Longhi S.p.A. ( BIT:DLG ) shareholders, with its shares surging 14% to €34.18 in...

GMO Internet Group, Inc. recently announced a quarterly dividend of ¥9.5 per share for the third quarter of FY2025, in line with its policy to return 50% of profits to shareholders. This move underlines the company's ongoing focus on shareholder value and highlights management's confidence in its financial stability. We'll explore how reaffirming a 50% profit return policy could shape the company's investment narrative and broader growth outlook. Find companies with promising cash flow...

The board of Fuller, Smith & Turner P.L.C. ( LON:FSTA ) has announced that it will pay a dividend of £0.0785 per share...

Last week's earnings announcement from EQL Pharma AB (publ) ( STO:EQL ) was disappointing to investors, with a sluggish...

Altron Limited ( JSE:AEL ) is about to trade ex-dividend in the next three days. Typically, the ex-dividend date is two...

When you see that almost half of the companies in the Pharmaceuticals industry in the United Kingdom have...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

It's been a good week for Recordati Industria Chimica e Farmaceutica S.p.A. ( BIT:REC ) shareholders, because the...

It is a pleasure to report that the Watches of Switzerland Group PLC ( LON:WOSG ) is up 38% in the last quarter. But...

RaySearch Laboratories AB (publ)'s ( STO:RAY B ) stock was strong after they recently reported robust earnings. We did...

Key Insights Significant control over Coca-Cola HBC by individual investors implies that the general public has more...

The market seemed underwhelmed by the solid earnings posted by Samhällsbyggnadsbolaget i Norden AB (publ) ( STO:SBB B...

Key Insights The projected fair value for Melexis is €54.64 based on 2 Stage Free Cash Flow to Equity With €55.65 share...

With a price-to-earnings (or "P/E") ratio of 18.1x Kerry Group plc ( ISE:KRZ ) may be sending bearish signals at the...

Key Insights Celtic's Annual General Meeting to take place on 21st of November Salary of UK£518.6k is part of CEO...